122 related articles for article (PubMed ID: 2568765)
1. Alcohol withdrawal syndrome: clinical and hormonal responses to alpha 2-adrenergic agonist treatment.
Cushman P; Sowers JR
Alcohol Clin Exp Res; 1989 Jun; 13(3):361-4. PubMed ID: 2568765
[TBL] [Abstract][Full Text] [Related]
2. Alcohol withdrawal syndromes: clinical management with lofexidine.
Cushman P; Forbes R; Lerner W; Stewart M
Alcohol Clin Exp Res; 1985; 9(2):103-8. PubMed ID: 3890587
[TBL] [Abstract][Full Text] [Related]
3. Intrathecal and oral clonidine as prophylaxis for postoperative alcohol withdrawal syndrome: a randomized double-blinded study.
Dobrydnjov I; Axelsson K; Berggren L; Samarütel J; Holmström B
Anesth Analg; 2004 Mar; 98(3):738-44, table of contents. PubMed ID: 14980929
[TBL] [Abstract][Full Text] [Related]
4. A Phase 3 placebo-controlled, double-blind, multi-site trial of the alpha-2-adrenergic agonist, lofexidine, for opioid withdrawal.
Yu E; Miotto K; Akerele E; Montgomery A; Elkashef A; Walsh R; Montoya I; Fischman MW; Collins J; McSherry F; Boardman K; Davies DK; O'Brien CP; Ling W; Kleber H; Herman BH
Drug Alcohol Depend; 2008 Sep; 97(1-2):158-68. PubMed ID: 18508207
[TBL] [Abstract][Full Text] [Related]
5. Alpha2-adrenergic agonists in opioid withdrawal.
Gowing LR; Farrell M; Ali RL; White JM
Addiction; 2002 Jan; 97(1):49-58. PubMed ID: 11895270
[TBL] [Abstract][Full Text] [Related]
6. Clonidine and alcohol withdrawal.
Cushman P
Adv Alcohol Subst Abuse; 1987; 7(1):17-28. PubMed ID: 3327372
[TBL] [Abstract][Full Text] [Related]
7. Effects of THC and lofexidine in a human laboratory model of marijuana withdrawal and relapse.
Haney M; Hart CL; Vosburg SK; Comer SD; Reed SC; Foltin RW
Psychopharmacology (Berl); 2008 Mar; 197(1):157-68. PubMed ID: 18161012
[TBL] [Abstract][Full Text] [Related]
8. Lofexidine, an {alpha}2-receptor agonist for opioid detoxification.
Gish EC; Miller JL; Honey BL; Johnson PN
Ann Pharmacother; 2010 Feb; 44(2):343-51. PubMed ID: 20040696
[TBL] [Abstract][Full Text] [Related]
9. Double-blind study of alprazolam, diazepam, clonidine, and placebo in the alcohol withdrawal syndrome: preliminary findings.
Adinoff B
Alcohol Clin Exp Res; 1994 Aug; 18(4):873-8. PubMed ID: 7978098
[TBL] [Abstract][Full Text] [Related]
10. The effect of placebo in the alcohol withdrawal state.
Lichtigfeld FJ; Gillman MA
Alcohol Alcohol; 1989; 24(2):109-12. PubMed ID: 2655625
[TBL] [Abstract][Full Text] [Related]
11. Alcohol withdrawal: effects of clonidine treatment on sympathetic activity, the renin-aldosterone system, and clinical symptoms.
Manhem P; Nilsson LH; Moberg AL; Wadstein J; Hökfelt B
Alcohol Clin Exp Res; 1985; 9(3):238-43. PubMed ID: 3893195
[TBL] [Abstract][Full Text] [Related]
12. Clonidine versus chlordiazepoxide in acute alcohol withdrawal: a preliminary report.
Baumgartner GR
South Med J; 1988 Jan; 81(1):56-60. PubMed ID: 3276009
[TBL] [Abstract][Full Text] [Related]
13. [Use of clonidine in the prevention of alcohol withdrawal syndrome].
Mondavio M; Ghiazza GF
Minerva Med; 1989 Nov; 80(11):1233-5. PubMed ID: 2689915
[TBL] [Abstract][Full Text] [Related]
14. A double-blind randomized placebo-controlled trial of lofexidine in alcohol withdrawal: lofexidine is not a useful adjunct to chlordiazepoxide.
Keaney F; Strang J; Gossop M; Marshall EJ; Farrell M; Welch S; Hahn B; Gonzalez A
Alcohol Alcohol; 2001; 36(5):426-30. PubMed ID: 11524309
[TBL] [Abstract][Full Text] [Related]
15. Bromocriptine in the treatment of the alcohol-withdrawal syndrome.
Borg V; Weinholdt T
Acta Psychiatr Scand; 1982 Feb; 65(2):101-11. PubMed ID: 6764859
[TBL] [Abstract][Full Text] [Related]
16. Hormonal, psychological, and alcohol craving changes after m-chlorophenylpiperazine administration in alcoholics.
Buydens-Branchey L; Branchey M; Fergeson P; Hudson J; McKernin C
Alcohol Clin Exp Res; 1997 Apr; 21(2):220-6. PubMed ID: 9113256
[TBL] [Abstract][Full Text] [Related]
17. Lofexidine in alcohol withdrawal states.
Brunning J; Mumford JP; Keaney FP
Alcohol Alcohol; 1986; 21(2):167-70. PubMed ID: 3741551
[TBL] [Abstract][Full Text] [Related]
18. Prophylaxis of alcohol withdrawal syndrome in alcohol-dependent patients admitted to the intensive care unit after tumour resection.
Spies CD; Dubisz N; Funk W; Blum S; Müller C; Rommelspacher H; Brummer G; Specht M; Hannemann L; Striebel HW
Br J Anaesth; 1995 Dec; 75(6):734-9. PubMed ID: 8672322
[TBL] [Abstract][Full Text] [Related]
19. A phase III, randomized, multi-center, double blind, placebo controlled study of safety and efficacy of lofexidine for relief of symptoms in individuals undergoing inpatient opioid withdrawal.
Gorodetzky CW; Walsh SL; Martin PR; Saxon AJ; Gullo KL; Biswas K
Drug Alcohol Depend; 2017 Jul; 176():79-88. PubMed ID: 28527421
[TBL] [Abstract][Full Text] [Related]
20. Oxcarbazepine--efficacy and tolerability during treatment of alcohol withdrawal: a double-blind, randomized, placebo-controlled multicenter pilot study.
Koethe D; Juelicher A; Nolden BM; Braunwarth WD; Klosterkötter J; Niklewski G; Wodarz N; Klatt J; Burtscheidt W; Gaebel W; Markus Leweke F
Alcohol Clin Exp Res; 2007 Jul; 31(7):1188-94. PubMed ID: 17511748
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
